The promoters of Aster DM Healthcare have raised their ownership in the company listed in India by 4% from 37.88% to 41.88%. This was done by purchasing extra shares from a major private equity investor at a cost of Rs 4.6 B or AED 207M.
Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare, said: “The increase of our stake in Aster DM Healthcare is a reiteration of our confidence in the business across geographies and our commitment to the patients and employees who have placed their trust in us. As a family we are fully committed to Aster and promise our continued involvement in GCC and India businesses both in terms of ownership and management.Aster DM Healthcare reported a turnover of Rs 102.53 B or AED 5B in FY 2021-22.
Aster is moving forward with various new projects in India, including the development of several hospitals such as the 350-bed Aster Capital Hospital in Trivandrum, Kerala, the 200-bed Aster MIMS Hospital in Kasargod, Kerala, the 150-bed Aster Narayanadri Hospital in Tirupati, Andhra Pradesh, and the 100-bed Aster G Madegowda Hospital in Mandya, Karnataka. Additionally, Aster has introduced 239 Aster pharmacies and 177 Aster Labs and patient experience centers.
Furthermore, Aster has launched the 181-bed Aster Royal Hospital in Oman and the 101-bed Aster Hospital in Sharjah, as well as acquired a 126-bed hospital in Al Qusais, which will result in Aster being one of the largest healthcare providers in GCC with 15 hospitals, 113 clinics, and 257 pharmacies. The company has also initiated a plan to introduce 250 new Aster Pharmacies in Saudi Arabia.
